Literature DB >> 1968704

Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family.

J H Auwerx1, S P Babirak, J E Hokanson, G Stahnke, H Will, S S Deeb, J D Brunzell.   

Abstract

A large family is reported with familial hepatic triglyceride lipase (HTGL) deficiency and with the coexistence of reduced lipoprotein lipase (LPL) similar to the heterozygote state of LPL deficiency. The proband was initially detected because of hypertriglyceridemia and chylomicronemia. He was later demonstrated to have beta-VLDL despite an apo E3/E3 phenotype and the lack of stigmata of type III hyperlipoproteinemia. The proband had no HTGL activity in postheparin plasma. Two of his half-sisters had very low HTGL activity (39 and 31 nmol free fatty acids/min/ml; normal adult female greater than 44). His son and daughters had decreased HTGL activity (normal male and preadolescent female greater than 102), which would be expected in obligate heterozygotes for HTGL deficiency. Low HTGL activity was associated with LDL particles which were larger and more buoyant. Several family members, including the proband, had reduced LPL activity and mass less than that circumscribed by the 95% confidence-interval ellipse for normal subjects and had hyperlipidemia similar to that described in heterozygote relatives of patients with LPL deficiency. All the sibs with hyperlipidemia had a reduced LPL activity and mass, while subjects with isolated reduced HTGL (with normal LPL activity) had normal lipid phenotypes. Analysis of genomic DNA from these subjects by restriction-enzyme digestion revealed no major abnormalities in the structure of either the HTGL or the LPL gene. Compound heterozygotes for HTGL and LPL deficiency show lipoprotein physiological characteristics typical for HTGL deficiency, while their variable lipid phenotype is typical for LPL deficiency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968704      PMCID: PMC1683625     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  On the metabolic function of heparin-releasable liver lipase.

Authors:  H Jansen; A van Tol; W C Hülsmann
Journal:  Biochem Biophys Res Commun       Date:  1980-01-15       Impact factor: 3.575

4.  Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats.

Authors:  T Murase; H Itakura
Journal:  Atherosclerosis       Date:  1981-06       Impact factor: 5.162

5.  Post-heparin lipolytic activity with no hepatic triacylglycerol lipase involved in a mammalian species.

Authors:  J Etienne; L Noé; M Rossignol; A M Dosne; J Debray
Journal:  Biochim Biophys Acta       Date:  1981-02-23

6.  Synthesis and secretion of lipolytic enzymes by cultured chicken hepatocytes.

Authors:  G L Jensen; D L Baly; P M Brannon; A Bensadoun
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

7.  Heterogeneity of primary lipoprotein lipase deficiency.

Authors:  J D Brunzell; A Chait; E A Nikkilä; C Ehnholm; J K Huttunen; G Steiner
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

8.  Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.

Authors:  P R Turner; N E Miller; C Cortese; W Hazzard; J Coltart; B Lewis
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.

Authors:  T Kuusi; P Saarinen; E A Nikkilä
Journal:  Atherosclerosis       Date:  1980-08       Impact factor: 5.162

10.  A selective deficiency of hepatic triacylglycerol lipase in guinea pigs.

Authors:  N Yamada; T Murase; Y Akanuma; H Itakura; K Kosaka
Journal:  Biochim Biophys Acta       Date:  1979-10-26
View more
  6 in total

1.  Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

Authors:  C Sandholzer; G Feussner; J Brunzell; G Utermann
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

3.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Authors:  E Tahvanainen; M Syvanne; M H Frick; S Murtomaki-Repo; M Antikainen; Y A Kesaniemi; H Kauma; A Pasternak; M R Taskinen; C Ehnholm
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium.

Authors:  D Applebaum-Bowden; J Kobayashi; V S Kashyap; D R Brown; A Berard; S Meyn; C Parrott; N Maeda; R Shamburek; H B Brewer; S Santamarina-Fojo
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

5.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.

Authors:  J Fan; J Wang; A Bensadoun; S J Lauer; Q Dang; R W Mahley; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Hepatic lipase deficiency in a Middle-Eastern-Arabic male.

Authors:  Nafila Al Riyami; Abdullah M Al-Ali; Ahmad J Al-Sarraf; John Hill; Kristina Sachs-Barrable; Robert Hegele; Kishor M Wasan; Jiri Frohlich
Journal:  BMJ Case Rep       Date:  2010-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.